In 1947, Major League Baseball Hall of Famer Babe Ruth, who was battling Nasopharynx cancer, became one of the first human subjects of teropterin (similar to aminopterin) treatment. Dr. Richard Lewisohn of Mount Sinai Hospital in New York administered the drug, and over the course of several months, Ruth's condition began to improve.